COVID-19: CDC, FDA and CMS Guidance
This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.
The Food and Drug Administration updated its guidance on enforcement policy for non-invasive remote monitoring devices that support patient monitoring during the COVID-19 public health emergency.
The Centers for Medicare & Medicaid Services announced an interim final rule establishing additional Medicare hospital payment to support Medicare beneficiaries鈥 access to COVID-19 vaccines and new treatments when they become available.
In partnership with the AHA鈥檚 Center for Health Innovation and other national health care organizations, the Centers for Disease Control and Prevention launched Project Firstline, a national training collaborative to help every health care worker understand and adhere to recommended infection鈥
The Food and Drug Administration released an updated template for developers requesting emergency use authorization for antigen tests for the COVID-19 virus.
The Department of Health and Human Services (HHS) today posted reports on its
According to an analysis of COVID-19 hospitalization data from 13 states, released by the Centers for Disease Control and Prevention, 6% of adults hospitalized with COVID-19 between March 1 and May 31 were health care personnel.
The Food and Drug Administration approved Veklury (remdesivir) to treat COVID-19 patients age 12 and older who are hospitalized and weigh at least 40 kilograms (about 88 pounds).
The Department of Health and Human Services (HHS) Oct. 22 issued a revision to its reporting requirements for providers that received Provider Relief Fund (PRF) payments. The notice includes revised data elements that recipients must submit for calendar years 2019 and 2020. Specifically, recipients鈥
U.S. counties with more racial and ethnic minority residents, people living in crowded housing and other social vulnerabilities were more likely to become COVID-19 hotspots in June and July, according to a study released by the Centers for Disease Control and Prevention.
The Centers for Disease Control and Prevention updated how it defines 鈥渃lose contact鈥 exposure to an individual infected with the COVID-19 virus to someone within 6 feet of the infected individual for 15 minutes or more cumulatively over a 24-hour period, rather than exposure within 6 feet for at鈥